Artificial hip maker demands retraction of a paper calling its research ‘grave fraudulence’
The article concluded that a J&J and DePuy clinical trial was a “seeding study,” designed to market the Pinnacle hip implant to doctors rather than present a test of its…
by Ivan Oransky and Adam Marcus
Jul 27, 2018
3 minutes
Last December, Brown University’s Dr. David Egilman and colleagues published a scholarly paper that identified serious flaws in a study of a hip prosthesis, and accused the medical device maker DePuy — a wholly owned subsidiary of J&J — of “grave fraudulence.”
“J&J/DePuy violated the study protocol and manipulated data; consented participants in violation of standards protecting human subjects; and did not secure Institutional Review Board approval for all study sites,” they of the companies’ Pinnacle metal-on-metal hip replacement system, which was taken off the market in 2013 after many patients had
You’re reading a preview, subscribe to read more.
Start your free 30 days